Join us Sept. 14-16 in Miami to connect with top publishing leaders
Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
Digiday+ Research: The marketers’ 2026 guide to retail media marketing, including The Home Depot, Milani Cosmetics and Tinuiti
As the retail media landscape continues to evolve, marketers are rethinking where they invest, how they measure success and which retail media networks deserve a larger share of budget.
Why more celebrity-led brands are shutting down
Celebrity-backed brands, once seen as surefire bets due to their founders’ built-in audiences, are increasingly facing a reality check.
In Graphic Detail: How AI search has impacted the web traffic of over 50 advertisers
Data spanning one agency’s entire client roster shows the true impact of AI search on web traffic and conversions.